Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
Holding XERS?
Track your performance easily

Xeris Pharmaceuticals (XERS) Income Statement

902 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q3 2023), Xeris Pharmaceuticals's total revenue was $48.32M, an increase of 62.56% from the same quarter last year. In Q3, Xeris Pharmaceuticals's net income was $-12.19M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Mar 23Dec 22Dec 21Dec 20
Total Revenue
$ 114.66M$ 38.01M$ 33.20M$ 110.25M$ 49.59M$ 20.43M
Cost of Revenue
$ 14.49M$ 7.55M-$ 22.63M$ 13.32M$ 9.33M
Gross Profit
$ 100.17M$ 30.45M$ 33.20M$ 87.61M$ 36.27M$ 11.11M
Operating Expense
$ 136.41M$ 46.43M$ 41.15M$ 169.55M$ 151.43M$ 94.65M
Operating Income
$ -28.04M$ -15.98M$ -7.96M$ -81.94M$ -115.16M$ -83.55M
Net Non Operating Interest Income Expense
$ -13.17M$ -5.30M$ -4.92M$ -12.75M$ -6.87M$ -7.70M
Other Income Expense
$ 4.96M$ -767.00K$ -1.36M$ -1.40M$ -702.00K$ -9.00K
Pretax Income
$ -42.63M$ -20.52M$ -16.83M$ -96.08M$ -122.72M$ -91.25M
Tax Provision
$ -676.00K$ -675.00K-$ -1.42M$ 0.00$ -110.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -41.95M$ -19.84M$ -16.83M$ -94.66M$ -122.72M$ -91.14M
Basic EPS
$ -0.31$ -0.14$ -0.12$ -0.70$ -1.55$ -2.14
Diluted EPS
$ -0.31$ -0.14$ -0.12$ -0.70$ -1.55$ -2.14
Basic Average Shares
$ 411.19M$ 137.34M$ 137.14M$ 135.63M$ 79.03M$ 42.64M
Diluted Average Shares
$ 411.19M$ 137.34M$ 137.14M$ 135.63M$ 79.03M$ 42.64M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 150.90M$ 53.99M$ 41.15M$ 192.19M$ 164.75M$ 103.98M
Net Income From Continuing And Discontinued Operation
$ -41.95M$ -19.84M$ -16.83M$ -94.66M$ -122.72M$ -91.14M
Normalized Income
$ -17.24M$ -21.97M-$ -93.28M$ -122.02M$ -91.13M
Interest Expense
$ 4.37M--$ 15.32M$ 7.18M$ 10.66M
EBIT
$ -25.20M$ -13.99M$ -11.92M$ -80.76M$ -115.55M$ -80.59M
EBITDA
$ -14.99M$ -7.15M$ -9.21M$ -68.09M$ -113.67M$ -79.12M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis